We demonstrated that an HDAC8-selective inhibitor lowered blood pressure, inhibited vascular hypertrophy and inflammation, and relaxed blood vessels in an Ang II-induced hypertension model. This evidence concerns the gene HDAC8 and hypertensive disorder.